Analyst Consensus
- Current Price
- 1,098.57 $
- Target (Low)
- 850.00 $
- Target (Mean)
- 1,218.72 $
- Target (High)
- 1,500.00 $
- Recommendation
- Buy
- Number of Analysts
- 29
Recommendation Distribution
Recommendation Distribution| Strong Buy | 6 |
|---|
| Buy | 18 |
|---|
| Hold | 5 |
|---|
| Sell | 1 |
|---|
| Strong Sell | 1 |
|---|
Key Ratios
- Net Profit Margin
- 35.0%
- Operating Margin
- 49.4%
- Gross Margin
- 82.8%
- Return on Equity (ROE)
- 107.5%
- Return on Assets (ROA)
- 20.7%
- Revenue Growth
- 55.5%
- Earnings Growth
- 169.9%
- Debt/Equity
- 139.02
- Current Ratio
- 1.50
- Beta
- 0.52
Recent Rating Changes
Recent Rating Changes| Date | Firm | Change |
|---|
| Jun 9, 2026 | Jefferies | Buy → Buy |
| May 26, 2026 | B of A Securities | Buy → Buy |
| May 5, 2026 | Barclays | Overweight → Overweight |
| May 5, 2026 | Guggenheim | Buy → Buy |
| May 4, 2026 | Wolfe Research | Outperform → Outperform |
| May 1, 2026 | Cantor Fitzgerald | Overweight → Overweight |